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Abstract 
 
Voltage-gated sodium channels are the target of several insecticides including DTT, 
pyrethroids, and SCBIs like indoxacarb and metaflumizone. SCBIs are an alternative 
insecticide resistance management (IRM) strategy against several pests resistant to 
other compounds. However, resistance to SCBIs has been reported in several pests, in 
most cases implicating metabolic resistance mechanisms, although  in certain 
indoxacarb resistant populations of Plutella xylostella and Tuta absoluta,  two 
mutations in the domain IV S6 segment of the voltage-gated sodium channel, F1845Y 
and V1848I have been identified, and have been postulated through in vitro 
electrophysiological studies to contribute to target-site resistance.  
In order to functionally validate in vivo each mutation in the absence of confounding 
resistance mechanisms, we have employed a CRISPR/Cas9 strategy to generate strains 
bearing homozygous F1845Y or V1848I mutations in the para (voltage-gated sodium 
channel) gene of Drosophila melanogaster. We performed toxicity bioassays of these 
strains compared to wild-type controls of the same genetic background. Our results 
indicate both mutations confer moderate resistance to indoxacarb (RR: 6 – 10.2), and 
V1848I to metaflumizone (RR: 8.4). However, F1845Y confers very strong resistance 
to metaflumizone (RR: >3400), a finding that may be related to the specific binding of 
each insecticide to its target. 
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1. Introduction 
Voltage-gated sodium channels (VGSCs) are important transmembrane proteins, 
in the cells of nervous system in animals, since they are responsible for the passage of 
sodium ions across the plasma membrane, leading to the generation and propagation of 
electrical signals facilitating the response to several environmental stimuli (see review 
by Carnevale and Klein, 2017). The VGSC α-subunits are comprised by four 
homologous domains (I-IV), each having six membrane spanning helical segments (S1-
S6); sodium ions are sensed by positively charged aminoacids of the S4 transmembrane 
segments (Duclohier, 2009). In response to membrane depolarization, the S4 segments 
move to the extracellular side of the cell membrane, triggering an allosteric alteration 
to the coupling between the sensor module and the gate that is contained within the 
assembly of the S5 and S6 transmembrane helices. This leads to pore opening, initiating 
the influx of sodium ions (Dong et al, 2014; Carnevale and Klein, 2017). Soon after, 
the sodium channel undergoes inactivation through two different modes, one of fast 
inactivation which is served by the inactivation particle occluding the cytoplasmic end 
of the pore (an intracellular loop linking domains III and IV of the α-subunit and 
containing a characteristic IFM amino acid motif; Goldin, 2003) and another mode of 
slow inactivation whose molecular basis is still not elaborated (Kass, 2004; Silva, 2014). 
Since they are major players of cell excitability in the nervous system, VGSCs are 
the primary targets of many chemical substances such as local anesthetics (analgetics, 
antirrhythmic drugs) in vertebrates as well as chemical insecticides in insects, which 
are used in order to suppress the cells’ excitability and their high frequency discharges 
(Gawali et al., 2015). These chemicals’ efficiency lies on their affinity to the inactivated 
4 
 
state of the sodium channels. Many types of insecticides such as DDT and pyrethroids 
target the nervous system, by prolonging the channel’s open conformation state, 
resulting to the increase of Na+ influx and finally to cell hyperexcitability (Wakeling et 
al., 2012). Indoxacarb (a pyrazoline type insecticide) and metaflumizone belong to the 
family of Sodium Channel Blocker Insecticides (SCBIs; von Stein et al., 2013) that has 
a different mode of action (Group 22A in the IRAC classification system). Both target 
the sodium channel in the slow-inactivated state in a fashion similar to local anesthetics, 
by binding to the opened channel pore when the membrane is still depolarized and 
causing a shift in the voltage dependence of slow inactivation to more negative currents. 
Thus, VGSCs are stabilized in the inactivated state leading to hindrance of the 
intracellular sodium influx (Silver & Soderlund, 2007; Silver et al., 2010; 2017; Jiang 
et al., 2015, Zhang et al, 2016).  
Indoxacarb is an insecticidal oxadiazine characterized as a pro-insecticide since it 
has to be converted to the active metabolite N-decarbomethoxylated JW062 (DCJW), 
a secondary product generated by the hydrolyzing activity of insect esterases or 
amidases, which underlies its action selectivity against insects (Zhang et al., 2016). 
Indoxacarb formulations are used either by spraying or by digestion and the desirable 
effects (cessation of feeding, lack of coordination and paralysis) are observed from 
within few minutes to four hours. It is used against moths, beetles, leafhoppers, weevils, 
flies and other pests (Silver et al., 2010) and it has been shown that spraying treatment 
of Drosophila with DCJW is effective and eventually causes mortality (Zhang et al., 
2013). Metaflumizone belongs to the category of semicarbazones, which are ring-
opened dihydropyrazoles (von Stein et al., 2013), and it is a different SCBI developed 
by BASF in an effort to overcome the side effects of dihydropyrazoles. Metaflumizone 
exhibits low toxicity to mammals and selectivity towards insects (Hempel et al., 2007). 
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The use of SCBIs has been a significant alternative insecticide resistance 
management (IRM) strategy against several pests resistant to other compounds. 
However, cases of resistance against SCBIs have been reported in insects such as the 
housfly Musca domestica (Shono et al., 2004), the lepidopteran pests Choristoneura 
rosaceana (Ahmad et al., 2002), Plutella xylostella (Khakame et al., 2013; Wang et al., 
2016; Zhang et al., 2017), Spodoptera exigua (Tian et al., 2014), Helicoverpa armigera 
(Bird et al., 2017) and Tuta absoluta (Roditakis et al., 2017) and the cockroach Blatella 
germanica (Liang et al., 2017).  
The cross resistance spectrum between Indoxacarb and Metaflumizone is not clear: 
indoxacarb selected T. absoluta strains exhibit only limited Resistance Ratio (RR) 
increase for metaflumizone (Roditakis et al., 2017), while earlier studies of indoxacarb-
resistant populations of P. xylostella indicate no cross-resistance to metaflumizone 
(Khakame et al., 2013). Conversely, a report of a population of Spodoptera exigua 
developing 942-fold resistance to metaflumizone, but only 16-fold resistance to 
indoxacarb (Su & Sun, 2014). On the other hand, selection of indoxacarb in the field 
confers cross-resistance to metaflumizone in at least one population of P. xylostella 
(Wang et al., 2016).  
In some cases there is evidence for synergistic effects of metabolic inhibitors on 
SCBI toxicity, implicating metabolic resistance mechanisms through esterases or 
oxidases (Wang et al., 2016; Liang et al., 2017). 
However, synergists only partially reduced resistance against indoxacarb in T. 
absoluta (Roditakis et al., 2017), while their use suggested a limited role of 
detoxification in metaflumizone resistance in Spodoptera exigua (Su & Sun, 2014). 
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Resistance levels to both SCBIs were significantly correlated to the frequencies of 
two sodium channel mutations, F1845Y and V1848I, identified in the domain IV S6 
segment of the voltage-gated sodium channel, (Figure 1) in two field populations of P. 
xylostella exhibiting resistance to indoxacarb (Wang et al., 2016). The same mutations 
were identified in SCBI-resistant populations of T. absoluta, collected from tomato 
greenhouses from Italy and Greece (Roditakis et al., 2017).  
An in vitro approach for the investigation of F1845 and V1848 mutations (P. 
xylostella numbering) with SCBIs binding was performed through heterologous 
expression of modified german cockroach B. germanica voltage gated sodium channel 
in Xenopus oocytes for electrophysiological experiments where  F1845Y and 
V1848I/A mutants were generated (Jiang et al., 2015).  This in vitro assessment 
suggested that single amino acid mutations F1845Y and V1848I (but not V1848A) in 
the cockroach sodium channel reduced almost equally the inhibition of sodium current 
by indoxacarb, DCJW (an active metabolite of indoxacarb) and metaflumizone, 
indicating that both these specific mutations might contribute to non-selective target-
site resistance against both SCBIs. However, in vivo genetic functional validation of 
these mutations has not been documented so far.  
In recent years, genome engineering through CRISPR/Cas9 technology has been 
employed in several insecticide resistance studies in model systems like Drosophila or 
in pest species where the technology has been established (reviewed in Perry and 
Batterham, 2018; Homem and Davies, 2018), providing useful information about the 
association of specific mutations with resistance against several insecticide classes, like 
spinosyns that target nicotinic acetylcholine receptor (Somers et al., 2015; Zimmer et 
al., 2016), etoxazole and benzoylureas targeting chitin synthase (Douris et al., 2016; 
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Grigoraki et al., 2017) and diamides targeting ryanodine receptor (Douris et al., 2017; 
Zuo et al., 2017). In this study we have employed a CRISPR/Cas9 strategy in order to 
generate Drosophila strains bearing homozygous F1845Y or V1848I mutations in the 
para (voltage-gated sodium channel) gene, and performed toxicity bioassays these 
strains in order to functionally validate resistance to SCBIs in vivo.  
 
2. Materials and Methods 
2.1 Chemicals 
Chemical compounds used for contact bioassays were indoxacarb (Sigma-Aldrich, 
PubChem CID: 107720) and Metaflumizone (Sigma-Aldrich, PubChem CID: 
11614934). The formulations used for feeding bioassays were Steward 30 WG (DuPont) 
for indoxacarb, and Alverde 24 SC (BASF) for metaflumizone. 
2.2 Fly strains  
The injections for genome modification of Drosophila were performed in 
preblastoderm embryos of the lab strain y1 M{nos-Cas9.P}ZH-2A w*, in which Cas9 
is expressed under the control of nanos promoter (Port et al., 2014; further below 
referred as nos.Cas9, #54591 in Bloomington Drosophila stock center). Strain 
w+oc/FM7yBHw (kindly provided by professor Christos Delidakis, IMBB and 
University of Crete) which contains the X chromosome balancer FM7c was used for 
genetic crosses and for keeping heterozygous mutants. The flies were kept at 25oC 
temperature, at 60-70% humidity and 12:12 hour photoperiod on a typical fly diet.  
2.3 Amplification and sequencing of para target region 
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DNA from nos.Cas9 Drosophila adults was extracted with DNAzol (MRC) 
following the manufacturer instructions. Three sets of primers (Inv1F/R, Inv2F/R and 
Inv3F/R, Table 1) were designed based on the para gene sequence in order to amplify 
three overlapping fragments (Inv1-3) that add up to a 3134bp region encompassing 
genomic region X:16,466,144-16,463,017 of the Drosophila genome sequence 
(numbering according to BDGP6 genome assembly). The amplification reactions were 
performed using KapaTaq DNA Polymerase (Kapa Biosystems). The conditions were 
95oC for 2 min for initial denaturation followed by 30-35 cycles of denaturation at 95oC 
for 30 sec, annealing at 61oC-66oC for 15 sec, extension at 72oC for 45-90 sec and a 
final extension step for 2 min. The PCR products were purified with a PCR clean-up 
kit (Macherey Nagel) according to manufacturer’s instructions. Sequencing of the 
products was performed from both ends at StarSeq (Maintz, Germany).  
2.4 Strategy for genome editing 
An ad hoc CRISPR-Cas9 strategy was implemented in order to generate 
Drosophila strains bearing either one or both mutations (relevant to F1845Y and 
V1848I found in P. xylostella and T. absoluta) in the para gene (voltage-gated sodium 
channel). We used the same CRISPR targets but different donor constructs for 
homologous-directed repair for the generation of each strain, containing either F1845Y 
or V1848I (or both, further below referred as FYVI). Based on the genomic sequence 
of para obtained for strain nos.Cas9, several CRISPR targets in the desired region were 
identified using the Optimal Target Finder online tool (Gratz et al., 2014, 
http://tools.flycrispr.molbio.wisc.edu/targetFinder). Two target sequences found 
upstream (Lpara) and downstream (Rpara) of the desired region in para gene were 
selected (Figure 2) with no predicted off-target effects. In order to generate sgRNAs 
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targeting those sequences, two different RNA expressing plasmids were generated 
based on the vector pU6-BbsI chiRNA (Gratz et al., 2013) following digestion with 
BbsI and ligation of two double stranded oligos, (dsLpara and dsRpara), which were 
generated by annealing single stranded oligos RparaF/RparaR and LparaF/LparaR 
(Table 1) respectively. Following ligation and transformation, single colonies for each 
construct were picked and checked for the correct insert by performing colony PCR 
using T7 universal primer and the reverse primer for each dsDNA. The sequence of 
each sgRNA expressing plasmid was verified by sequencing (Macrogen, Amsterdam). 
Three different donor plasmids, paraF1845Y, paraV1848I and paraFYVI were 
synthesized de novo (Genscript) to facilitate Homologous Directed Repair for 
generations of strains F1845Y, V1848I and FYVI respectively (relevant insert 
sequences shown in Figure S1). Each plasmid contained two ~1000 bp homology arms 
flanking the 228 bp target region between the two sgRNA targets Lpara and Rpara. The 
target region was specifically designed (see Figure 2 for details) in order to contain the 
desired in each case combination of desired mutations along with certain synonymous 
mutations serving either as molecular markers in order to facilitate molecular screening 
of CRISPR events, or to prevent unwanted CRISPR digestion of the donor itself.  
2.5 Molecular screening and genetic crosses  
Injection of nos.Cas9 pre-blastoderm embryos was performed at the 
IMBB/FORTH facility with injection mixes containing 75 ng/μl of each sgRNA 
expressing vector and 100ng/μl of donor template. Hatched larvae were transferred into 
standard fly artificial diet and after 9-13 days G0 surviving adults were collected and 
individually backcrossed with nos.Cas9 flies. In order to screen for CRISPR events, G1 
generation progeny from each cross were pooled into batches of ~30 and genomic DNA 
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extraction was performed en masse in order to be screened with two different ways. 
Initially, 2μg of gDNA was digested with HindIII (for F1845Y and FYVI crosses) or 
BsrGI (for V1848I); these enzymes cut only the wild type alleles but not potential 
mutant alleles in each DNA pool. Then, one strategy for screening consists of 
amplification with specific primers ParaSpecF/R (Table S1) that were designed taking 
into account the synonymous mutations introduced in the two sgRNA target sequences 
in all donor templates, in order to generate a diagnostic fragment of 250bp that is 
specific to genome modified alleles, but not wild-type ones. PCR was performed with 
Kapa Taq polymerase as previously described using ~60 ng of digested template DNA 
mix. An alternative strategy consists of PCR amplification with the “generic” primer 
pair ParaGenF/R (Table S1) which were designed in order to amplify a fragment of 752 
bp that may be derived by either wild type (if still present, given the initial enzymatic 
cleavage of the template DNA mix) or genome modified alleles. Following PCR 
amplification, the product was digested with diagnostic enzymes introduced in the HDR 
donor sequence, namely KpnI for F1845Y (producing two diagnostic fragments of 536 
bp and 217 bp), BclI for V1848I (producing two diagnostic fragments of 405 bp and 
347 bp) and XbaI for FYVI (producing two fragments of 437 bp and 315 bp). 
Crosses that proved positive for genome modified alleles were further explored in 
order to identify individual flies bearing mutant alleles and establish homozygous lines 
(see Figure 4 for the whole crossing scheme). Individual G1 flies from positive original 
G0 crosses were back-crossed with nos.Cas9 and after generating G2 progeny, they 
underwent molecular screening as previously described. Positive crosses now contain 
the mutant allele in 50% of the G2 progeny. Individual female G2 flies were then crossed 
with male flies carrying a balancer X chromosome (FM7c) with a characteristic 
phenotypic marker (Bar). After producing G3 progeny, the female G2 flies were again 
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individually screened to identify positive crosses, and female G3 flies potentially 
carrying the mutant allele opposite of an FM7c balancer were again back-crossed with 
male flies carrying FM7c balancer to produce G4 progeny. One final round of molecular 
screening was performed to identify balanced lines containing the genome modified 
allele against FM7c, and G5 adults were collected following phenotypic selection 
against the Bar marker and pooled in order to establish  homozygous strains. DNA was 
extracted from several homozygous female and hemizygous male adults, amplified by 
using primers ParaGenF/R and the relevant amplification fragment was sequence 
verified (Macrogen, Amsterdam). 
2.6 Toxicity Bioassays  
Contact Bioassays: Insecticidal activity against adult flies was tested by residual 
contact application on nos.Cas9 flies. Test insecticides were dissolved in acetone and 
serial dilutions were prepared to make desired concentrations. A volume of 500 μl of 
each one was applied into glass scintillation vials. For each concentration there were 3 
technical replicates. The vials were put on a roller for overlaying their entire surface for 
30-40 min under a fume hood. Following the evaporation of acetone, 20 flies (10 males 
and 10 females, 1-3 day adults) were transferred into each vial. Individual vials were 
covered with a piece of cotton soaked into a solution of 5% sucrose. Vials were 
maintained at room temperature and flies were exposed for 24-96 hours.  
Feeding Toxicity Bioassays: For feeding bioassays, 2nd instar larvae were transferred in 
batches of 20 into fresh standard fly artificial food, supplemented with several 
concentrations of insecticide formulation solutions. Larval development, mortality, 
pupal eclosion, pupal size and adult survival were monitored and measured for 7-10 
days. Each bioassay consisted of five to seven different concentrations, tested in 
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triplicates. Control population (nos.Cas9) was tested along with the genome modified 
populations (F1845Y, and V1848I) and for each insecticide negative controls (no 
insecticide) were included.  
Statistical analyses: Concentration-response data of each bioassay setup were collected 
and analyzed with ProBit analysis using PoloPlus (LeOra Software, Berkeley, 
California) in order to calculate Lethal Concentrations of the 50% of the population 
subjected to the experiment (LC50 values), 95% fiducial limits (FL), linearity of the 
dose-mortality response, construction of mortality curves and statistical significance of 
the results.  
3. Results 
3.1 Generation of Drosophila strains bearing mutations F1845Y and/or V1848I at the 
para gene. 
The mutations F1845Y and V1848I (P. xylostella numbering) in segment S6 of 
domain IV were introduced in Drosophila via a CRISPR/Cas9 coupled with 
Homologous Directed Repair (HDR) genome modification strategy. The voltage-gated 
sodium channel of Drosophila, paralytic or para was aligned to the lepidopteran and 
other insect orthologs (Fig.1B) and the target region identified. A genome modification 
strategy was designed in order to introduce the mutations under study (Fig. 2) and 
carried out as described in Materials and Methods.   
Embryos of nos.Cas9 flies (expressing Cas9 under nanos promoter) were injected 
with three different plasmid mix combinations, each containing two sgRNA target 
plasmids (Lpara, Rpara) and one of the donor plasmids paraF1845Y, paraV1848I or 
paraFYVI. For the F1845Y mutation, 55 adult flies derived from injected embryos (G0) 
were crossed with nos.Cas9 flies. Nine crosses were sterile, while the progeny of the 
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remaining 46 (G1) were screened with two different molecular screening approaches as 
described in Experimental Procedures. Six out of the 46 crosses were found to be 
positive for HDR. Regarding the V1848I mutation, 55 G0 flies were crossed to nos.Cas9 
and 21 of them were sterile. The remaining 34 crosses that provided G1 progeny were 
screened and eight were positive for HDR. Finally, for FYVI (bearing both mutations), 
71 crosses were set, 56 gave G1 progeny and were screened, and six were found to be 
positive for HDR. 
 G1 individuals originating from the original positive lines (G0) were crossed, 
screened (Fig. 3) and then balanced in order to establish homozygous fly lines for each 
mutation (overall crossing scheme shown in Figure 4). Following the final crosses in 
order to obtain homozygous modified flies, six lines homozygous for the F1845Y 
mutation and four lines homozygous for the V1848I mutation were established and 
sequence verified. However, for all five FYVI lines that were eventually generated 
bearing both mutations in the same allele, no homozygous females or hemizygous 
positive males were ever generated, and the FYVI allele had to be kept as heterozygote 
over balancer chromosome.  
3.2 Validation of ability of F1845Y and V1848I mutations to confer resistance to SCBIs 
in Drosophila 
In order to validate toxicity of SCBIs in Drosophila, contact bioassays were 
performed in 2-3 day old adult nos.Cas9 flies. No mortality was observed even after 96 
hours of continuous exposure to a concentration of 1000 μg/ml of either indoxacarb or 
metaflumizone.  
Then, feeding toxicity bioassays were performed with 2nd instar larvae that were 
collected and transferred into fresh food containing several concentrations of each 
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insecticide. Drosophila larvae were continuously in contact with the food supplemented 
with the insecticides. Toxicity effects such as cessation of feeding, larval paralysis, 
prolonged development and reduction of the size of pupae were observed. Since dead 
larvae cannot be readily visible inside the fly food, molting to pupae was considered a 
measurable proxy of eventual survival (most pupae eclose normally 7-10 days after the 
bioassay is initiated). Survival data underwent probit analysis and the corresponding 
LC50 values and resistance ratios versus the control (nos.Cas9) flies, along with 95% 
fiducial limits and associated statistics are shown in Table 1. 
According to these findings, flies bearing the F1845Y mutation in homozygous 
(female) / hemizygous (male) state, exhibit 10.2-fold resistance to indoxacarb 
compared to nos.Cas9 wild type controls. On the other hand, the same flies exhibit 
much higher resistance to metaflumizone (RR: >3400 with respect to nos.Cas9). Flies 
bearing the mutation V1848I, show similar moderate levels of resistance both to 
indoxacarb (RR: 6) and to metaflumizone (RR: 8.4) compared to wild-type (nos.Cas9) 
controls. These results were confirmed in several experiments using different fly lines 
bearing the mutations, with limited LC50 variation among different experiments, within 
the fiducial limits shown in Table 1. 
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4. Discussion 
Two mutations at the S6 segment of domain IV of voltage-gated sodium channel 
(F1845Y and V1848I, P. xylostella numbering) have been reported in resistant 
populations of two pest species, Plutella xylostella (Wang et al., 2016) and Tuta 
absoluta (Roditakis et al., 2017) and have been implicated to SCBI resistance through 
in vitro studies where the relevant mutations are introduced in cockroach sodium 
channels expressed in Xenopus oocytes (Jiang et al., 2015). In the present study, we 
employed a reverse genetics approach to induce these mutations through CRISPR/Cas9 
genome modification at the para (sodium channel) gene of Drosophila melanogaster 
whose IVS6 sequence is very similar to the sequence of the two lepidopteran pests 
(Figure 1B). We generated genome modified fly strains bearing each mutation and 
performed toxicity bioassays against two commercial SCBIs, indoxacarb and 
metaflumizone.  
Our results (Table 1) provide direct in vivo confirmation that both F1845Y and 
V1848I have an effect on resistance against both commercial SCBIs. However, in 
contrast to previous in vitro characterisation studies (Jiang et al 2015), this effect is not 
uniform for each mutation/insecticide combination. Toxicity bioassays against different 
concentrations of indoxacarb indicate that both F1845Y and V1848I confer comparable, 
low to moderate ratios of resistance compared to wild-type controls (RR: 10.2 and 6 
respectively). On the contrary, toxicity bioassays against metaflumizone indicate that 
although V1848I also confers resistance of similar scale (RR: 8.4), the F1845Y 
mutation has a much stronger impact by several orders of magnitude (RR: 3441.2), a 
result obtained in several independent experiments. 
16 
 
Although available in vitro evidence suggests that both mutations reduce the 
sensitivity of the cockroach channel to both insecticides (Jiang et al. 2015), the level of 
reduction is not substantially different among different mutation / insecticide 
combinations. Although the two approaches are not readily comparable, it is 
noteworthy that in vitro the percentage of inhibition by metaflumizone in F1845Y and 
V1848I mutant cockroach channels is virtually the same (Jiang et al., 2015; Table 2), 
i.e. both mutations induce approximately the same reduction of sensitivity, in sharp 
contrast with the in vivo Drosophila bioassay results where F1845Y flies are >400 times 
more resistant to metaflumizone compared to V1848I ones. 
The specific conformational changes induced by each mutation (and thus the 
resulting resistance observed) may be very much dependent on the protein sequence 
context. Jiang et al. (2015) suggest that the SCBIs interact with both valine V1848 and 
phenylalanine F1845 (P. xylostella numbering), and propose a homology model based 
prediction for DCJW binding, according to which “the [V1848] sidechain faces the 
inner pore, whereas the [F1845] sidechain may move between the inner pore and the 
III/IV domain interface. […] SCBIs bind in the inner pore and may expand a 
hydrophobic moiety into the III/IV domain interface.” (Jiang et al., 2015).  In a follow-
up study that includes docking simulations of metaflumizone (Zhang et al., 2016), the 
two positions are described as “SCBI sensing residues” and it is proposed that the SCBI 
receptor includes certain residues in IVS6 (F1845, V1848 and possibly Y1852), as well 
as at least one other residue in IIS6 that faces the pore, but does not contribute to LA 
binding, while it contributes to the metaflumizone receptor (Zhang et al., 2016; Silver 
et al., 2017). Other residues may also participate in binding SCBIs to VGSCs (Silver et 
al., 2017). 
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Our finding that F1845Y mutation in genome modified flies has a much greater 
impact on metaflumizone resistance compared either to indoxacarb or to the impact of 
V1848I against both commercial SCBIs, provided it mirrors the actual situation in 
lepidopteran pest, might be indicative of a much more critical role of residue 1845 for 
metaflumizone binding to the SCBI receptor. Indoxacarb and metaflumizone belong to 
the same IRAC class and have a common target, but they belong to different chemical 
classes and their structure is substantially different; thus, there may be differences in 
their specific binding sites and respective binding properties as already documented for 
at least one residue that affects channel sensitivity to metaflumizone, but not indoxacarb 
or DCJW (von Stein & Soderlund, 2012). Detailed in silico analysis and additional 
experiments are necessary in order to fully understand the specific interactions, but the 
outcome of this study may already have important implication in IRM with impact on 
crop production.  
 Our effort to generate a homozygous fly strain carrying both mutations at the same 
allele (in cis) was not successful; although such a “dual” allele has been generated by 
CRISPR/Cas9 coupled with homologous recombination, it was always found in 
heterozygotes and no homozygous flies bearing both mutations in cis could be 
generated. Interestingly, heterozygotes from resistant populations of P. xylostella have 
also been found to always have the two mutations in trans (single) and never in cis 
(“dual” allele; Wang et al., 2016), and similarly in resistant T. absoluta (data not shown; 
samples from Roditakis et al., 2017) This is a strong indication that the two mutations 
are mutually exclusive, i.e. that the “dual” allele bearing both mutations is not viable, 
leading to a non-functional sodium channel conformation. 
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Drosophila is versatile system that enables multiple questions to be addressed in a 
common genetic framework, providing the sophisticated toolkit required for such an 
operation. The establishment of genome modification technology in insecticide 
resistance studies in combination with standard genetic engineering may facilitate 
validation of target-site resistance to SCBIs (as in this study) as well as co-existing 
synergistic mechanisms of metabolic resistance as soon as candidate genes for these 
become available for investigation.  
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Table 1: Log-dose probit-mortality data for indoxacarb and metaflumizone against larvae of Drosophila 
genome modified strains F1845Y and V1848I versus nos.Cas9 control. 
 
 
  
Compound Drosophila 
strain 
Slope ±se LC50 (95% CI) 
ug/ml 
X2 (df) RR vs 
nos.Cas9 
Indoxacarb nos.Cas9 4.012 ±0.360 2.756  
(2.416-3.133) 
17.406 (14) 1 
F1845Y 3.901 ±0.370 28.202 
(25.547-31.209) 
14.782 (17) 10.2  
V1848I 4.270 ±0.352 16.658 
(15.124-18.434) 
14.555 (22) 6  
Metaflumizone nos.Cas9 4.983 ±0.598  0.525 
(0.479-0.575) 
9.375 (10) 1 
F1845Y 5.906 ±0.798 1816.675 
(1627.624-2017.529) 
8.748 (16) 3441.2  
V1848I 2.964 ±0.331 4.412 
(3.763-5.131) 
12.111 (13) 6.45  
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Table S1: List of primers used in this study 
 
 
 
 
  
No. Primer name Primer sequence (5'->3') Experimental use 
1 Tuta_F  GTGCTGGACGGCATCATCAA Amplification from Tuta absoluta 
DNA samples 
2 Tuta_R CTCGAGAATGACGGCGATGT 
3 LparaF CTTCGAGGAGAAACGTTATTCCAA Generation of sgRNA expression 
plasmids  
4 LparaR AAACTTGGAATAACGTTTCTCCTC 
5 RparaF CTTCGTCCGAATTCCTGGACGTAC 
6 RparaR AAACGTACGTCCAGGAATTCGGAC 
7 ParaSpecF AATTGTGGTTCAGCGACGGTTGGC Molecular screening for genome 
modified flies 
8 ParaSpecR GGGGCTCAAGTACATCCAGGAAC 
9 ParaGenF TCGCACAACTGCCAATCCTA 
10 ParaGenR CACCAATCTCACCCGTCTCC 
11 Ind1F CCTCTGTCTATCTGTCTGCC Sequencing of overlapping 
fragments of para genomic region 
12 Ind1R ATACGAGCGTGTTACCGATT 
13 Ind2F GCCCACATACGAACACTCCG 
14 Ind2R CGTATGTACTGGGTGCCCTC 
15 Ind3F ATCCACCCGACAACGACAAA 
16 Ind3R TACCGTCATTTGCTCGCCAT 
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Figure Legends 
Figure 1: Positions of sodium channel mutations in the voltage-gated sodium channel 
(modified from Wang et al., 2016) and sequence alignment of the IVS6 segment. A: 
The sodium channel consists of four main domains (I–IV) and six transmembrane 
segments (S1–S6) within each domain. The two mutations in IVS6 related to sodium 
channel blocker insecticide resistance are shown. The amino acid positions are 
numbered based on a Plutella xylostella sequence (GenBank accession no. KM027335). 
B: Sequence alignment of the IVS6 segment of sodium channels from different insects. 
The mutation sites (F1845Y and V1848I) are shown in boxes.. PxNav: P. xylostella 
(GenBank accession no. KM027335); TaNav: Tuta absoluta susceptible strain 
(Roditakis et al., 2017); LepF1845Y: Lepidopteran (P. xylostella and T. absoluta) 
sequence with mutation F1845Y); LepV1848I: Lepidopteran (P. xylostella and T. 
absoluta sequence with mutation V1848I); DmNav: Drosophila melanogaster 
(AAB59193.1); DmF1845Y: D. melanogaster sequence with mutation F1845Y; 
DmV1848I: D. melanogaster sequence with mutation V1848I. AgNav: Anopheles 
gambiae (CAM12801.1); AmNav: Apis mellifera (NP_001159377.1); TcNav: 
Tribolium castaneum (NP_001159380.1).BgNav: Blattella germanica (AAC47484.1). 
 
Figure 2: CRISPR/Cas9 strategies for generation of genome modified flies bearing 
mutations F1845Y (A), V1848I (B), or both (C). Nucleotide and deduced amino acid 
sequence of a 258 bp fragment of para (corresponding to reverse complement of X: 
16358465-16358722 at the BDGP6 genome assembly), flanking positions 1845 and 
1848 (P. xylostella numbering) of the Drosophila melanogaster amino acid sequence. 
Light gray areas indicate the CRISPR/Cas9 targets selected (LPara sgRNA,Rpara 
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sgRNA), while dark gray areas indicate the corresponding PAM (-NGG) triplets. 
Vertical arrows denote break points for CRISPR/Cas9-induced double stranded breaks. 
Ovals mark non-synonymous differences between target (wild-type) and donor 
(genome modified) sequences. Synonymous mutations incorporated for diagnostic 
purposes, as well as to avoid cleavage of the donor plasmid by the CRISPR/Cas9 
machinery, are shown above the nucleotide sequence. Restriction sites abolished 
because of the genome modification are shown with double strikethrough letters and 
the corresponding sequence is underlined. Restriction sites introduced because of the 
genome modification are shown in dashed boxes and the corresponding sequence is 
also underlined.   
 
Figure 3: Indicative diagnostic screening with specific primers yielding a 250 bp PCR 
product in 2% agarose gel electrophoresis. M: molecular weight marker (100 bp ladder); 
+: positive control (PCR using as template the relevant donor plasmid for each 
mutation); -: negative control (PCR using as template DNA from non-injected nos.Cas9 
flies; NTC: blank (no DNA template). (A) PCR screening of G1 individuals backcrossed 
with nos.Cas9 originating from each original line (G0) for the F1845Y mutation. (B) 
Diagnostic KpnI digestion of PCR product (752 bp) amplified with generic primers for 
massively screening G1 progeny samples of injected G0 flies yielding two diagnostic 
fragments of 536 bp and 217 bp. (C) PCR screening with specific primers (250 bp 
product) in pools of G1 progeny of the original injected flies for the dual mutations 
FYVI. (D) PCR screening with specific primers (250bp) of G1 individuals for the 
mutation V1848I after cross with flies bearing balancer FM7. 
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Figure 4: Crossing scheme for Drosophila. Several nos.Cas9 G0 embryos are injected 
and surviving adults back-crossed to nos.Cas9 The G1 progeny is sampled (n≈30) and 
if positive, individual G1 flies are crossed to nos.Cas9 and then screened with single fly 
PCR for homologous directed repair (HDR). Individual G2 feamles are crossed to males 
of a strain bearing X chromosome balancer FM7c marked with Bar and then screened 
for HDR. Individual G3 females with heterozygous Bar phenotype are crossed to the 
balancer strain males and then screened for HDR. G4 females with Bar phenotype 
(bearing the desired mutation opposite to FM7c) are crossed with male siblings selected 
against Bar (i.e. hemizygous for the genome modified chromosome bearing the HDR-
derived allele) and their progeny (G5) is selected against Bar to generate homozygous 
lines bearing the desired mutation. 
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          PAM   Lpara sgRNA                         F1845Y    
           G     C        C                         A        
GGTTCAGCGACCGTTGGAATAACGTTTCTCCTCTCATACCTAGTTATAAGCTTTTTGATAGTTATTAATATGTACATTGCTGTCATTCTCGAGAACTATAGTCAGGCCACCGAGGACGTGCAAGAGGGT    
 G  S  A  T  V  G  I  T  F  L  L  S  Y  L  V  I  S  F  L  I  V  I  N  M  Y  I  A  V  I  L  E  N  Y  S  Q  A  T  E  D  V  Q  E  G  
                                               HindIII             
 
                                                                                         Rpara sgRNA      PAM                                     
                                                           T                                G        T     T  
CTAACCGACGACGACTACGACATGTACTATGAGATCTGGCAGCAATTCGATCCGGAGGGCACCCAGTACATACGCTATGATCAGCTGTCCGAATTCCTGGACGTACTGGAGCCCCCGCTGCAGATCCAC 
 L  T  D  D  D  Y  D  M  Y  Y  E  I  W  Q  Q  F  D  P  E  G  T  Q  Y  I  R  Y  D  Q  L  S  E  F  L  D  V  L  E  P  P  L  Q  I  H 
                                                           KpnI                            EcoRI       
                                                                                                                                                                      
 
         
     
                                                                                         
          PAM   Lpara sgRNA                                  V1848I    
           G     C        C                                CA             T 
GGTTCAGCGACCGTTGGAATAACGTTTCTCCTCTCATACCTAGTTATAAGCTTTTTGATAGTTATTAATATGTACATTGCTGTCATTCTCGAGAACTATAGTCAGGCCACCGAGGACGTGCAAGAGGGT    
 G  S  A  T  V  G  I  T  F  L  L  S  Y  L  V  I  S  F  L  I  V  I  N  M  Y  I  A  V  I  L  E  N  Y  S  Q  A  T  E  D  V  Q  E  G  
                                                        BclI           BsrGI 
 
                                                                                         Rpara sgRNA      PAM                                     
                                                                                            G        T     T  
CTAACCGACGACGACTACGACATGTACTATGAGATCTGGCAGCAATTCGATCCGGAGGGCACCCAGTACATACGCTATGATCAGCTGTCCGAATTCCTGGACGTACTGGAGCCCCCGCTGCAGATCCAC 
 L  T  D  D  D  Y  D  M  Y  Y  E  I  W  Q  Q  F  D  P  E  G  T  Q  Y  I  R  Y  D  Q  L  S  E  F  L  D  V  L  E  P  P  L  Q  I  H 
                                                                                            EcoRI       
                                                                                                                                                                      
 
          PAM   Lpara sgRNA                         F1845Y   V1848I 
           G     C        C                         A      CA                            A 
GGTTCAGCGACCGTTGGAATAACGTTTCTCCTCTCATACCTAGTTATAAGCTTTTTGATAGTTATTAATATGTACATTGCTGTCATTCTCGAGAACTATAGTCAGGCCACCGAGGACGTGCAAGAGGGT    
 G  S  A  T  V  G  I  T  F  L  L  S  Y  L  V  I  S  F  L  I  V  I  N  M  Y  I  A  V  I  L  E  N  Y  S  Q  A  T  E  D  V  Q  E  G  
                                               HindIII  BclI                         XbaI XhoI 
 
                                                                                         Rpara sgRNA      PAM                                     
                                                                                            G        T     T  
CTAACCGACGACGACTACGACATGTACTATGAGATCTGGCAGCAATTCGATCCGGAGGGCACCCAGTACATACGCTATGATCAGCTGTCCGAATTCCTGGACGTACTGGAGCCCCCGCTGCAGATCCAC 
 L  T  D  D  D  Y  D  M  Y  Y  E  I  W  Q  Q  F  D  P  E  G  T  Q  Y  I  R  Y  D  Q  L  S  E  F  L  D  V  L  E  P  P  L  Q  I  H 
                                                                                            EcoRI       
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